Insider Trading Alerts


Image for Savaria (TSE:SIS) Director Peter Allen Drutz Sells 9,736 Shares
Savaria (TSE:SIS) Director Peter Allen Drutz Sells 9,736 Shares

Savaria Co. (TSE:SIS - Get Free Report) Director Peter Allen Drutz sold 9,736 shares of the company's stock in a transaction on Saturday, June 6th. The stock was sold at an average price of C$29.00, for a total value of C$282,344.00. Following the sale, the director owned 95,251 shares of the company's stock, valued at C$2,762,279. This trade represents a 9.27% decrease in their ownership of the stock.


Image for Pelangio Exploration (CVE:PX) Director Ingrid Jo-Ann Hibbard Buys 75,000 Shares
Pelangio Exploration (CVE:PX) Director Ingrid Jo-Ann Hibbard Buys 75,000 Shares

Pelangio Exploration Inc. (CVE:PX - Get Free Report) Director Ingrid Jo-Ann Hibbard bought 75,000 shares of the company's stock in a transaction that occurred on Thursday, June 4th. The shares were bought at an average cost of C$0.15 per share, for a total transaction of C$11,250.00. Following the completion of the acquisition, the director owned 14,870,346 shares of the company's stock, valued at C$2,230,551.90. This trade represents a 0.51% increase in their ownership of the stock.


Image for Foxx Development (NASDAQ:FOXX) CTO James Liao Sells 1,943 Shares
Foxx Development (NASDAQ:FOXX) CTO James Liao Sells 1,943 Shares

Foxx Development Holdings Inc. (NASDAQ:FOXX - Get Free Report) CTO James Liao sold 1,943 shares of the stock in a transaction dated Thursday, June 4th. The stock was sold at an average price of $6.15, for a total transaction of $11,949.45. Following the transaction, the chief technology officer owned 19,431 shares of the company's stock, valued at $119,500.65. This represents a 9.09% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.


Image for Insider Selling: NAMI (NASDAQ:NAMI) CFO Sells 41,364 Shares of Stock
Insider Selling: NAMI (NASDAQ:NAMI) CFO Sells 41,364 Shares of Stock

NAMI Corp. (NASDAQ:NAMI - Get Free Report) CFO Jun Jason Jiang sold 41,364 shares of the business's stock in a transaction dated Wednesday, June 3rd. The stock was sold at an average price of $0.29, for a total transaction of $11,995.56. Following the transaction, the chief financial officer owned 2,933,966 shares in the company, valued at approximately $850,850.14. The trade was a 1.39% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink.


Image for Riskified (NYSE:RSKD) Director Sells $12,553.80 in Stock
Riskified (NYSE:RSKD) Director Sells $12,553.80 in Stock

Riskified Ltd. (NYSE:RSKD - Get Free Report) Director Erez Shachar sold 2,562 shares of Riskified stock in a transaction that occurred on Wednesday, June 3rd. The shares were sold at an average price of $4.90, for a total value of $12,553.80. Following the completion of the sale, the director directly owned 4,671,968 shares in the company, valued at $22,892,643.20. This represents a 0.05% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website.


Image for Progyny (NASDAQ:PGNY) EVP Allison Swartz Sells 599 Shares
Progyny (NASDAQ:PGNY) EVP Allison Swartz Sells 599 Shares

Progyny, Inc. (NASDAQ:PGNY - Get Free Report) EVP Allison Swartz sold 599 shares of the business's stock in a transaction on Thursday, June 4th. The stock was sold at an average price of $25.08, for a total value of $15,022.92. Following the completion of the sale, the executive vice president directly owned 82,378 shares in the company, valued at $2,066,040.24. This trade represents a 0.72% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.


Image for Adient (NYSE:ADNT) EVP Sells $15,783.42 in Stock
Adient (NYSE:ADNT) EVP Sells $15,783.42 in Stock

Adient (NYSE:ADNT - Get Free Report) EVP David Herberg sold 699 shares of the stock in a transaction on Thursday, June 4th. The stock was sold at an average price of $22.58, for a total transaction of $15,783.42. Following the completion of the sale, the executive vice president directly owned 40,122 shares of the company's stock, valued at $905,954.76. The trade was a 1.71% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link.


Image for David Weiant Sells 1,000 Shares of Provident Financial (NASDAQ:PROV) Stock
David Weiant Sells 1,000 Shares of Provident Financial (NASDAQ:PROV) Stock

Provident Financial Holdings, Inc. (NASDAQ:PROV - Get Free Report) SVP David Weiant sold 1,000 shares of the business's stock in a transaction dated Thursday, June 4th. The shares were sold at an average price of $17.10, for a total transaction of $17,100.00. Following the transaction, the senior vice president owned 9,919 shares in the company, valued at $169,614.90. This represents a 9.16% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link.


Image for Cadrenal Therapeutics (NASDAQ:CVKD) CEO Quang Pham Sells 3,898 Shares
Cadrenal Therapeutics (NASDAQ:CVKD) CEO Quang Pham Sells 3,898 Shares

Cadrenal Therapeutics, Inc. (NASDAQ:CVKD - Get Free Report) CEO Quang Pham sold 3,898 shares of Cadrenal Therapeutics stock in a transaction dated Thursday, June 4th. The shares were sold at an average price of $4.41, for a total value of $17,190.18. Following the completion of the sale, the chief executive officer directly owned 175,288 shares in the company, valued at approximately $773,020.08. This represents a 2.18% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.


Image for Insider Selling: Docusign (NASDAQ:DOCU) Director Sells 363 Shares of Stock
Insider Selling: Docusign (NASDAQ:DOCU) Director Sells 363 Shares of Stock

Docusign Inc. (NASDAQ:DOCU - Get Free Report) Director Anna Marrs sold 363 shares of the company's stock in a transaction on Friday, June 5th. The shares were sold at an average price of $49.42, for a total value of $17,939.46. Following the completion of the sale, the director directly owned 12,977 shares in the company, valued at $641,323.34. This trade represents a 2.72% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.


Image for Insider Buying: SurgePays (NASDAQ:SURG) Director Acquires 34,716 Shares of Stock
Insider Buying: SurgePays (NASDAQ:SURG) Director Acquires 34,716 Shares of Stock

SurgePays, Inc. (NASDAQ:SURG - Get Free Report) Director David Allen May acquired 34,716 shares of the company's stock in a transaction that occurred on Friday, June 5th. The stock was acquired at an average cost of $0.53 per share, for a total transaction of $18,399.48. Following the acquisition, the director owned 156,626 shares of the company's stock, valued at $83,011.78. The trade was a 28.48% increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website.


Image for Insider Selling: MiNK Therapeutics (NASDAQ:INKT) Director Sells 1,500 Shares of Stock
Insider Selling: MiNK Therapeutics (NASDAQ:INKT) Director Sells 1,500 Shares of Stock

MiNK Therapeutics, Inc. (NASDAQ:INKT - Get Free Report) Director Barbara Ryan sold 1,500 shares of the company's stock in a transaction on Thursday, June 4th. The stock was sold at an average price of $12.76, for a total transaction of $19,140.00. Following the completion of the transaction, the director directly owned 21,969 shares of the company's stock, valued at approximately $280,324.44. The trade was a 6.39% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website.


Image for Insider Buying: SmartRent (NYSE:SMRT) CEO Purchases 20,000 Shares of Stock
Insider Buying: SmartRent (NYSE:SMRT) CEO Purchases 20,000 Shares of Stock

SmartRent, Inc. (NYSE:SMRT - Get Free Report) CEO Frank Martell bought 20,000 shares of the company's stock in a transaction on Thursday, June 4th. The stock was bought at an average price of $1.19 per share, with a total value of $23,800.00. Following the completion of the acquisition, the chief executive officer owned 3,185,266 shares in the company, valued at $3,790,466.54. This represents a 0.63% increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.


Image for Baozun (NASDAQ:BZUN) CEO Buys $26,300.00 in Stock
Baozun (NASDAQ:BZUN) CEO Buys $26,300.00 in Stock

Baozun Inc. (NASDAQ:BZUN - Get Free Report) CEO Wenbin Qiu acquired 10,000 shares of the company's stock in a transaction on Wednesday, June 3rd. The stock was acquired at an average cost of $2.63 per share, for a total transaction of $26,300.00. Following the completion of the purchase, the chief executive officer directly owned 1,503,872 shares of the company's stock, valued at approximately $3,955,183.36. This represents a 0.67% increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is accessible through this hyperlink.


Image for Insider Selling: Arbe Robotics (NASDAQ:ARBE) CTO Sells 24,138 Shares of Stock
Insider Selling: Arbe Robotics (NASDAQ:ARBE) CTO Sells 24,138 Shares of Stock

Arbe Robotics Ltd. (NASDAQ:ARBE - Get Free Report) CTO Noam Arkind sold 24,138 shares of the company's stock in a transaction on Wednesday, June 3rd. The stock was sold at an average price of $1.09, for a total transaction of $26,310.42. Following the completion of the transaction, the chief technology officer directly owned 1,623,982 shares in the company, valued at $1,770,140.38. This trade represents a 1.46% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.


Image for MediaAlpha (NYSE:MAX) CTO Kuanling Amy Yeh Sells 3,000 Shares
MediaAlpha (NYSE:MAX) CTO Kuanling Amy Yeh Sells 3,000 Shares

MediaAlpha, Inc. (NYSE:MAX - Get Free Report) CTO Kuanling Amy Yeh sold 3,000 shares of the firm's stock in a transaction on Friday, June 5th. The stock was sold at an average price of $8.89, for a total value of $26,670.00. Following the transaction, the chief technology officer owned 569,985 shares of the company's stock, valued at approximately $5,067,166.65. This represents a 0.52% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards.


Image for Insider Selling: Keros Therapeutics (NASDAQ:KROS) Director Sells 2,625 Shares of Stock
Insider Selling: Keros Therapeutics (NASDAQ:KROS) Director Sells 2,625 Shares of Stock

Keros Therapeutics, Inc. (NASDAQ:KROS - Get Free Report) Director Alpna Seth sold 2,625 shares of the stock in a transaction on Thursday, June 4th. The stock was sold at an average price of $10.72, for a total value of $28,140.00. Following the completion of the transaction, the director owned 9,767 shares of the company's stock, valued at approximately $104,702.24. This trade represents a 21.18% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.


Image for Edible Garden (NASDAQ:EDBL) Major Shareholder Scott Wolinsky Buys 150,000 Shares
Edible Garden (NASDAQ:EDBL) Major Shareholder Scott Wolinsky Buys 150,000 Shares

Edible Garden AG Incorporated (NASDAQ:EDBL - Get Free Report) major shareholder Scott Wolinsky acquired 150,000 shares of Edible Garden stock in a transaction dated Friday, June 5th. The shares were acquired at an average cost of $0.19 per share, with a total value of $28,500.00. Following the completion of the acquisition, the insider directly owned 950,000 shares in the company, valued at $180,500. This trade represents a 18.75% increase in their position. The purchase was disclosed in a document filed with the SEC, which is accessible through this link. Major shareholders that own 10% or more of a company's stock are required to disclose their transactions with the SEC.


Image for Getty Images (NYSE:GETY) Insider Sells $30,099.00 in Stock
Getty Images (NYSE:GETY) Insider Sells $30,099.00 in Stock

Getty Images Holdings, Inc. (NYSE:GETY - Get Free Report) insider Michael Teaster sold 38,100 shares of the business's stock in a transaction dated Friday, June 5th. The shares were sold at an average price of $0.79, for a total value of $30,099.00. Following the completion of the transaction, the insider owned 488,862 shares in the company, valued at $386,200.98. The trade was a 7.23% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards.


Image for Insider Selling: Beta Bionics (NASDAQ:BBNX) Director Sells 2,811 Shares of Stock
Insider Selling: Beta Bionics (NASDAQ:BBNX) Director Sells 2,811 Shares of Stock

Beta Bionics, Inc. (NASDAQ:BBNX - Get Free Report) Director Christy Jones sold 2,811 shares of the business's stock in a transaction on Thursday, June 4th. The shares were sold at an average price of $14.00, for a total value of $39,354.00. Following the completion of the sale, the director owned 27,400 shares of the company's stock, valued at $383,600. This trade represents a 9.30% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.


Image for Insider Selling: Vinci Compass Investments (NASDAQ:VINP) CFO Sells 4,047 Shares of Stock
Insider Selling: Vinci Compass Investments (NASDAQ:VINP) CFO Sells 4,047 Shares of Stock

Vinci Compass Investments Ltd. (NASDAQ:VINP - Get Free Report) CFO Sergio Passos Ribeiro sold 4,047 shares of the stock in a transaction on Thursday, June 4th. The stock was sold at an average price of $9.79, for a total value of $39,620.13. Following the completion of the sale, the chief financial officer directly owned 250,776 shares in the company, valued at $2,455,097.04. This represents a 1.59% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.


Image for Avita Medical (NASDAQ:RCEL) Director Purchases $40,900.00 in Stock
Avita Medical (NASDAQ:RCEL) Director Purchases $40,900.00 in Stock

Avita Medical Inc. (NASDAQ:RCEL - Get Free Report) Director Joseph Fralin Woody bought 10,000 shares of the business's stock in a transaction on Wednesday, June 3rd. The shares were acquired at an average cost of $4.09 per share, for a total transaction of $40,900.00. Following the transaction, the director directly owned 92,761 shares in the company, valued at approximately $379,392.49. This trade represents a 12.08% increase in their position. The purchase was disclosed in a legal filing with the SEC, which is available through the SEC website.


Image for Editas Medicine (NASDAQ:EDIT) CEO Gilmore Neil O’neill Sells 15,380 Shares
Editas Medicine (NASDAQ:EDIT) CEO Gilmore Neil O'neill Sells 15,380 Shares

Editas Medicine, Inc. (NASDAQ:EDIT - Get Free Report) CEO Gilmore Neil O'neill sold 15,380 shares of the company's stock in a transaction on Wednesday, June 3rd. The shares were sold at an average price of $2.70, for a total transaction of $41,526.00. Following the sale, the chief executive officer directly owned 248,313 shares in the company, valued at $670,445.10. This trade represents a 5.83% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.


Image for Thomas Stepien Sells 2,000 Shares of Amprius Technologies (NYSE:AMPX) Stock
Thomas Stepien Sells 2,000 Shares of Amprius Technologies (NYSE:AMPX) Stock

Amprius Technologies, Inc. (NYSE:AMPX - Get Free Report) CEO Thomas Stepien sold 2,000 shares of Amprius Technologies stock in a transaction dated Thursday, June 4th. The stock was sold at an average price of $20.97, for a total value of $41,940.00. Following the completion of the transaction, the chief executive officer owned 625,625 shares in the company, valued at $13,119,356.25. The trade was a 0.32% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website.


Image for Equillium (NASDAQ:EQ) COO Christine Zedelmayer Sells 14,584 Shares
Equillium (NASDAQ:EQ) COO Christine Zedelmayer Sells 14,584 Shares

Equillium, Inc. (NASDAQ:EQ - Get Free Report) COO Christine Zedelmayer sold 14,584 shares of the firm's stock in a transaction that occurred on Friday, June 5th. The stock was sold at an average price of $2.93, for a total value of $42,731.12. Following the transaction, the chief operating officer owned 62,586 shares in the company, valued at $183,376.98. This represents a 18.90% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.


Image for FutureFuel (NYSE:FF) CEO Roeland Polet Buys 10,000 Shares
FutureFuel (NYSE:FF) CEO Roeland Polet Buys 10,000 Shares

FutureFuel Corp. (NYSE:FF - Get Free Report) CEO Roeland Polet purchased 10,000 shares of the stock in a transaction that occurred on Thursday, June 4th. The shares were purchased at an average price of $4.28 per share, with a total value of $42,800.00. Following the completion of the acquisition, the chief executive officer directly owned 35,000 shares in the company, valued at $149,800. The trade was a 40.00% increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link.


Image for Andrea Helen Simon Buys 5,000 Shares of MasterBrand (NYSE:MBC) Stock
Andrea Helen Simon Buys 5,000 Shares of MasterBrand (NYSE:MBC) Stock

MasterBrand, Inc. (NYSE:MBC - Get Free Report) CFO Andrea Helen Simon bought 5,000 shares of the business's stock in a transaction on Thursday, June 4th. The stock was purchased at an average price of $8.56 per share, for a total transaction of $42,800.00. Following the completion of the acquisition, the chief financial officer owned 497,341 shares of the company's stock, valued at approximately $4,257,238.96. This trade represents a 1.02% increase in their position. The acquisition was disclosed in a document filed with the SEC, which is available through this hyperlink.


Image for Insider Buying: Dyne Therapeutics (NASDAQ:DYN) Director Acquires 2,500 Shares of Stock
Insider Buying: Dyne Therapeutics (NASDAQ:DYN) Director Acquires 2,500 Shares of Stock

Dyne Therapeutics, Inc. (NASDAQ:DYN - Get Free Report) Director Brian Posner bought 2,500 shares of the company's stock in a transaction on Wednesday, June 3rd. The shares were acquired at an average price of $17.48 per share, for a total transaction of $43,700.00. Following the transaction, the director directly owned 22,500 shares in the company, valued at $393,300. This trade represents a 12.50% increase in their position. The transaction was disclosed in a document filed with the SEC, which is available through this link.


Image for John Stenbit Sells 653 Shares of Viasat (NASDAQ:VSAT) Stock
John Stenbit Sells 653 Shares of Viasat (NASDAQ:VSAT) Stock

Viasat Inc. (NASDAQ:VSAT - Get Free Report) Director John Stenbit sold 653 shares of Viasat stock in a transaction on Wednesday, June 3rd. The stock was sold at an average price of $71.74, for a total transaction of $46,846.22. Following the transaction, the director directly owned 29,597 shares of the company's stock, valued at approximately $2,123,288.78. This trade represents a 2.16% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website.


Image for Lee Ann Gliha Sells 258 Shares of Nexstar Media Group (NASDAQ:NXST) Stock
Lee Ann Gliha Sells 258 Shares of Nexstar Media Group (NASDAQ:NXST) Stock

Nexstar Media Group, Inc. (NASDAQ:NXST - Get Free Report) EVP Lee Ann Gliha sold 258 shares of the company's stock in a transaction dated Thursday, June 4th. The stock was sold at an average price of $182.42, for a total transaction of $47,064.36. Following the transaction, the executive vice president owned 18,387 shares in the company, valued at $3,354,156.54. The trade was a 1.38% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards.